BCAX — Bicara Therapeutics Inc

Ownership history in Siren, L.L.C. · 6 quarters on record

This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Bicara Therapeutics Inc (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

3.91% (2024 Q3)

Avg. % of fund

2.87%

First filed

2024 Q3

Last filed

2025 Q4

Quarters held

6

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	5,216,969	—	0%	2.62%	$87.8M	$16.83
2025 Q3	UNCHANGED	5,216,969	—	0%	3.22%	$82.4M	$15.79
2025 Q2	ADDED	5,216,969	+1,949,886	+59.7%	2.51%	$48.5M	$9.29
2025 Q1	REDUCED	3,267,083	-5,744	-0.2%	2.42%	$42.6M	$13.03

% of Fund (quarterly) BCAX price (monthly, adj. close)

Other funds also holding BCAX

As of 2025 Q4 — sorted by position size

Omega Fund Management, LLC 3Y 7Y 12.95% ACORN CAPITAL ADVISORS, LLC 3.67% Vestal Point Capital, LP 2.05% Aisling Capital Management LP 3Y 7Y 2.0% TPG GP A, LLC 3Y 1.89% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.2% DAFNA Capital Management LLC 3Y 7Y 1.02% Deep Track Capital, LP 3Y 0.78% Palo Alto Investors LP 3Y 7Y 0.7% Atle Fund Management AB 3Y 7Y 0.6%

← Back to Siren, L.L.C. Holdings